Researchers at Mayo Clinic found unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease, potentially leading to new diagnostic and treatment methods.
Researchers at Mayo Clinic discovered unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease. These signatures, published in Nature Communications, could lead to new ways to diagnose and treat the disease. The blood-brain barrier, essential for nourishing and protecting the brain, is disrupted in Alzheimer's, and these new findings highlight potential novel biomarkers to capture brain changes in the condition.
June 26, 2024
8 Articles